NEURO61

Session information

[held on paper]Oral Session

[O-01] Oral Session 01
Cerebrovascular disease (clinical research 1)

Tetsuya Chiba1,2, Kazuki Fukuma1, Katsunari Mamyo3, Naoki Tagawa1,2, Ruuna Kimihira1,2, Koudai Kanemaru1,2, Ritsuko Mitani3, Mayumi Fukuda2, Masatoshi Koga2, Masafumi Ihara1 (1.Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Japan, 2.Division of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan, 3.Department of Nursing, National Cerebral and Cardiovascular Center, Suita, Japan)

Natsuko Kato1,2, Kanako Muraga1,8, Yoshinori Hirata1, Akihiro Shindo1, Keita Matsuura1, Yuichiro Ii1, Mariko Shiga3, Ken-ichi Tabei2, Masayuki Satoh2,4, Satoshi Fujita5, Yoshihiko Kagawa5, Eitaro Fujii5, Masaaki Ito5, Maki Umino6, Masayuki Maeda6,7, Hidekazu Tomimoto1,2,3 (1.Department of Neurology, Graduate School of Medicine, Mie University, 2.Departrtment of Dementia Prevention and Therapeutics, 3.core-type Medical Center for Dementia, Mie University Hospital, 4.Dementia Center, Mie University Hospital, 5.Department of Cardiology, and Nephrology, Graduate School of Medicine, Mie University, 6.Department of Radiology, Graduate School of Medicine, Mie University, 7.Department of Advanced Diagnostic Imaging, Graduate School of Medicine, Mie University, 8.Department of Neurologic Science, Graduate School of Medicine, Nippon Medical School)